Europe

Pic:getty/oatawa

Astorg to acquire CordenPharma from ICIG

By Rachel Arthur

Astorg will acquire CDMO CordenPharma from ICIG: noting strong organic growth for the CDMO thanks to its position in fast-growing drug modalities such as mRNA vaccines, peptides and high-potency compounds notably for oncology therapeutics.